Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells
Authors:
Open Access
- 8 November 2006
- Vol. 107 (10) , 2425-2435
Abstract
BACKGROUND.: The over‐expression of the ephrin‐A1 ligand receptor EphA2 is associated with the growth and metastatic potential of tumors. Although EphA2 is expressed in a variety of tumors, its expression and function in malignant mesothelioma (MM) remain unknown. The authors hypothesized that expression of the receptor EphA2 in MM cells (MMCs) plays a key role in the growth and haptotactic migration of MM. They also hypothesized that silencing EphA2 expression by using small‐interfering RNA (siRNA) inhibits the proliferation and haptotaxis of MMCs and induces apoptosis in MMCs.METHODS.: The expression of EphA2 in MMCs and in normal pleural mesothelial cells (PMCs) was studied by using real‐time quantitative polymerase chain reaction analysis and Western blot analysis. The growth of MMCs was determined with the WST‐1 cell‐proliferation assay. The haptotactic migration of MMCs and PMCs was determined with a Boyden chamber assay. Expression of caspases was determined with calorimetric assays.RESULTS.: The results demonstrated that silencing the receptor EphA2 by siRNA significantly reduced the proliferation and haptotactic migration of MMCs compared with controls. Over‐expression of EphA2 with plasmid pcDNA/EphA2 enhanced the proliferation and haptotaxis of MMCs significantly. Knocking down EphA2 expression initiated caspase‐9–mediated apoptosis in MMCs.CONCLUSIONS.: The current results suggested that constitutive expression of EphA2 may contribute to the aggressive behavior and cellular survival of MMCs. EphA2 may be an effective therapeutic target in patients with mesothelioma. Silencing the receptor EphA2 gene is a novel approach for the containment of growth and migration of tumor in patients with malignant mesothelioma. Cancer 2006. © 2006 American Cancer Society.Keywords
This publication has 26 references indexed in Scilit:
- EphA2 Expression Is Associated with Aggressive Features in Ovarian CarcinomaClinical Cancer Research, 2004
- Vascular endothelial growth factor is an autocrine growth factor in human malignant mesotheliomaThe Journal of Pathology, 2001
- The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularizationOncogene, 2000
- Immunoreactivity for cadherins, HGF/SF, met, and erbB‐2 in pleural malignant mesotheliomasHistopathology, 2000
- Overexpression of the EphA2 tyrosine kinase in prostate cancerThe Prostate, 1999
- ECK,a HumanEPH-Related Gene, Maps to 1p36.1, a Common Region of Alteration in Human CancersGenomics, 1997
- Overexpression of Protein Tyrosine Kinases in Human Esophageal CancerPathobiology, 1997
- Distinct and Overlapping Expression Patterns of Ligands for Eph-Related Receptor Tyrosine Kinases during Mouse EmbryogenesisDevelopmental Biology, 1996
- Continuing increase in mesothelioma mortality in BritainThe Lancet, 1995
- Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells.Journal of Cell Biology, 1990